Investment Analysts’ Price Target Changes for May 19th (ARMK, BMRN, CSGP, EFX, FICO, HD, HIMS, OBIO, RLAY, TRU)

Investment Analysts’ price target changes for Tuesday, May 19th:

Aramark (NYSE:ARMK) had its target price boosted by Bank of America Corporation from $54.00 to $59.00. The firm currently has a buy rating on the stock.

BioMarin Pharmaceutical (NASDAQ:BMRN) had its price target reduced by Bank of America Corporation from $85.00 to $80.00. They currently have a buy rating on the stock.

CoStar Group (NASDAQ:CSGP) had its price target lowered by Bank of America Corporation from $42.00 to $37.00. The firm currently has a neutral rating on the stock.

Equifax (NYSE:EFX) had its price target cut by Bank of America Corporation from $250.00 to $225.00. Bank of America Corporation currently has a buy rating on the stock.

Fair Isaac (NYSE:FICO) had its target price cut by Bank of America Corporation from $1,550.00 to $1,400.00. The firm currently has a buy rating on the stock.

Home Depot (NYSE:HD) had its target price trimmed by BNP Paribas Exane from $348.00 to $325.00. They currently have a neutral rating on the stock.

Hims & Hers Health (NYSE:HIMS) had its target price trimmed by Bank of America Corporation from $30.00 to $28.00. Bank of America Corporation currently has a neutral rating on the stock.

Orchestra BioMed (NASDAQ:OBIO) had its price target trimmed by B. Riley Financial, Inc. from $12.00 to $10.00. B. Riley Financial, Inc. currently has a buy rating on the stock.

Relay Therapeutics (NASDAQ:RLAY) had its target price increased by Raymond James Financial, Inc. from $23.00 to $26.00. The firm currently has a strong-buy rating on the stock.

TransUnion (NYSE:TRU) had its target price lowered by Bank of America Corporation from $83.00 to $80.00. The firm currently has a neutral rating on the stock.

Verisk Analytics (NASDAQ:VRSK) had its target price lowered by Bank of America Corporation from $225.00 to $190.00. The firm currently has a neutral rating on the stock.